The first annual meeting of the EU-funded project ZIKAVAX took place on 7 December 2017 at CEA, Fontenay-aux-Roses, France.
During this meeting, the consortium members reviewed the recent data and agreed on the action plan for the coming months. The meeting was attended by two representatives of the independent scientific advisory committee, who gave valuable recommendations and advice for the future activities of the project. After the meeting, the participants had the opportunity to visit the laboratories and the facilities at CEA, where the immunogenicity and efficacy studies in non-human primates will be performed.